| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |